Syverson Strege & Co’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$239K Sell
504
-14
-3% -$7.05K 0.06% 145
2025
Q4
$242K Sell
518
-21
-4% -$9.75K 0.06% 141
2025
Q3
$230K Sell
539
-57
-10% -$22.1K 0.06% 146
2025
Q2
$228K Buy
+596
New +$215K 0.05% 148
2023
Q2
Sell
-22
Closed -$5.8K 298
2023
Q1
$5.8K Buy
+22
New +$5.59K ﹤0.01% 315
2021
Q4
Sell
-43
Closed -$10K 376
2021
Q3
$10K Buy
+43
New +$10.5K 0.01% 239

Other funds holding HCA

Syverson Strege & Co's HCA Position: Q1 2026 in Review

Syverson Strege & Co reduced its HCA Healthcare (HCA) stake by 2.7% in Q1 2026, selling an estimated $7.05K and leaving 504 shares worth $239K. The position accounts for 0.06% of the portfolio, ranked #145.

Syverson Strege & Co first reported a position in HCA in Q3 2021 and has held it in 6 quarters since. The position peaked at $242K in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Syverson Strege & Co held 504 shares of HCA Healthcare worth $239K as of Q1 2026.
  • Syverson Strege & Co sold 14 HCA Healthcare shares in Q1 2026, an estimated $7.05K.
  • HCA Healthcare made up 0.06% of Syverson Strege & Co's portfolio in Q1 2026, its #145 holding.
  • Syverson Strege & Co first reported a position in HCA Healthcare in Q3 2021 and has held it in 6 quarters since.
  • Syverson Strege & Co's HCA Healthcare position peaked at $242K in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Syverson Strege & Co's 13F filing for Q1 2026, filed 4 May 2026.